TODAY, Friday, November 20, 2020, 12p via Zoom

Today's Cancer Center Seminar features Heather Greenlee, ND, PhD, MPH presenting the Helen Moss Lecture, "The Future of Integrative Oncology" at noon via Zoom.

Dr. Greenlee is Associate Professor, Cancer Prevention Program, Public Health Sciences & Clinical Research Divisions at Fred Hutchinson Cancer Research Center.

Dr. Greenlee is a public health researcher and naturopathic physician who focuses on cancer prevention and control, cancer survivorship, obesity and cancer, and integrative medicine. She studies the effects of dietary change, physical activity and weight loss on cancer outcomes and designs lifestyle interventions to reduce cancer risk and better the life of cancer survivors, particularly in underserved populations. Dr. Greenlee also studies the use of integrative therapies such as acupuncture, massage, botanicals, vitamins/minerals and mind-body approaches to improve cancer symptoms, alleviate treatment side effects and improve survivors’ quality of life. She has helped create national guidelines on the use of integrative therapies during and after breast cancer treatment and was a co-investigator on the first large, randomized trial that showed acupuncture relieves joint pain caused by hormone-suppressing drugs in early-stage breast cancer patients. Dr. Greenlee also studies dietary and physical activity interventions among Latina breast cancer survivors; predictors of cardiovascular disease in breast cancer survivors; and the association between physical activity, the gut microbiome and risk of colorectal cancer.

Friday, December 4, 2020, 12p via Zoom

There will be no seminar next Friday, November 27 due to the holiday.

Our next Cancer Center Seminar welcomes Adam Bass, MD presenting, "Translating the Genome in Gastroesophageal Cancer" on behalf of the GI Cancer Genetics Program 12 pm ET on December 4.

Dr. Bass is Associate Professor of medicine at Harvard Medical School and Assistant Professor of medicine in the division of cellular and molecular oncology at Dana-Farber Cancer Institute. The overarching goal of his lab is to leverage the study the cancer genome to elucidate key biological processes and therapeutic vulnerabilities in carcinomas arising in the GI tract, especially stomach and esophageal carcinomas.

The Case Comprehensive Cancer Center Office of Community Outreach and Engagement is pleased to present the 5th Annual Cancer Disparities Symposium, Navigating Cancer Disparities: Lessons Learned and How to Move Forward.

Registration is now open for this multi-disciplinary event for researchers, clinicians, health professionals, community outreach groups, community-based organizations, patient advocates and trainees. Keynote presentations will be delivered by renowned disparities researchers and community leaders, and a poster session highlighting academic research and community programs will provide a showcase of the depth and depth of work happening in this field.

Though the symposium is happening virtually, attendees will experience the conference using Whova, our official web-based conference app, to view presentations and ask questions in real-time, as well as network with others behind the scenes.

Multidisciplinary researchers, community agencies and organizations are invited to submit abstracts for presentation at the 5th Annual Cancer Disparities Symposium. Abstracts will be divided into two tracks: Scientific Research and Community Programs. Meritorious abstracts will be selected for pre-recorded presentations. Abstracts must be submitted electronically by 5 pm ET on Friday, January 22, 2021.

Otis W. Brawley, MD, an internationally-recognized expert in cancer prevention and control, will present the symposium's Scientific Keynote His work is focused on closing racial, economic and social disparities in prevention, detection and treatment of cancer in the United States and worldwide.

Worta McCaskill-Stevens, MD, a medical oncologist nationally known for her expertise in bringing clinical trials to the community will present the Community Keynote. Dr. McCaskill-Stevens is Chief of the Community Oncology and Prevention Trials Research Group, which houses the National Cancer Institute (NCI) Community Oncology Research Program (NCORP), a community-based clinical trials network launched in 2014.

AIPNO is a vibrant large non-profit organization in the state of Ohio founded in 1983 geared toward enhancing the quality of healthcare by fostering excellence and professionalism in the practice of medicine and supporting efforts to improve the availability of healthcare to underserved populations in Ohio and in India. The mission of AIPNO is to continue to enhance community involvement and coordinate with other local, national and international organizations through philanthropy, health care access and education.

AIPNO is for non-Indians as well. The AIPNO Annual Event and Conference is one of their most prestigious events and includes a Research Showcase (complimentary registration for poster presenters and winners awarded cash prizes). AIPNO fosters and encourages participation from high school students, medical students, residents, fellows, faculty, nurses, seasoned researchers, allied healthcare providers (nurses, therapists, etc.), community leaders, legislative leaders, philanthropic practitioners, dedicated donors and valued beneficiaries alike.

Are you a high school student, medical student, resident, fellow, faculty, nurse, seasoned researcher or allied healthcare provider (therapist, etc.), interested in presenting your case study or research? AIPNO will accept abstracts for poster presentations held virtually as part of the 8th Annual Research Showcase Poster Competition from 4-5 pm on Saturday, December 5, 2020. View abstract guidelines.

Questions? Contact Pam Pawelecki at admin@aipno.org.

This course, co-directed by Janice Lyons, MD and John Suh, MD will provide radiation oncologists, radiation physicists, nurses, and others with the most current data and information that have been presented at the national meetings.

John Suh, MD, FASTRO and Janice Lyons, MD

Chirag Shah, MD

Samuel Chao, MD

Suzanne Russo, MD

Gregory Videtic, MD, FASTRO

Gordon Guo, MD

Neil Woody, MD

Sudha Amarnath, MD

Aryavarta Kumar, MD, PhD

Please email Sheryl Krall at kralls2@ccf.org to register.

Registration is open for the American Society of Hematology's all-virtual Annual Meeting and Exposition, taking place Saturday, December 5 through Tuesday, December 8. Attend the world’s most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates on the most critical topics in hematology.

The schedule-at-a-glance and the preliminary schedule and program for the 62nd ASH Annual Meeting and Exposition are now available, and abstracts have been recently posted.

The San Antonio Breast Cancer Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

The symposium is comprised of prestigious award lectures, educational sessions, career development forum, special global session, special session presented by Tigerlily Foundation & AACR, plenary lectures, mini-symposia, clinical, translational & basic science forums, work shops, case discussions and more! The schedule at a glance and daily schedule are now posted online.

Registration fees for the virtual symposium has been reduced.

Patients with cancer often have widely divergent care experiences from screening through survivorship. Differences in care delivery and outcomes may be due, in part, to varying patient needs and preferences according to age and stage of life; inconsistent implementation of guidelines, recommendations, and policies; and unintended age bias in health care.

The National Comprehensive Cancer Network’s® (NCCN®) Virtual Patient Advocacy Summit will provide an opportunity for a varied group of stakeholders including patients, caregivers, providers, patient advocacy organizations, policymakers, and industry to thoughtfully discuss the importance of providing quality, effective, efficient, and accessible cancer care across the patient lifespan.